Acitemate
Alternative Names: CH 123; Chinoin 123; VapedrineLatest Information Update: 31 Mar 1995
At a glance
- Originator Chinoin
- Developer Chinoin; Mitsubishi Chemical
- Class Antihyperlipidaemics
- Mechanism of Action HMG-CoA reductase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Hyperlipidaemia
Most Recent Events
- 31 Mar 1995 Discontinued-III for Hyperlipidaemia in Hungary (PO)
- 15 Feb 1995 Discontinued-II for Hyperlipidaemia in Japan (PO)